Page URL: https://www.bionews.org.uk/page_93041

Gene therapy used to cure blindness in monkeys

27 June 2011
Appeared in BioNews 613

A group of US scientists has successfully used a virus to deliver genes into monkey retinas that could potentially restore damaged photoreceptor cells. The findings could lead to gene therapies being developed to treat blindness and other eye conditions in humans.

In previous trials, researchers have used the AAV2 serotype of the adeno-associated virus to partially cure congenital blindness in retinal pigment epithelial cells. Treating problems in the photoreceptor layer of retinal cells, which are faulty in most inherited forms of blindness, has however proven far more difficult.

Dr Luk Vandenberghe and his colleagues at the University of Pennsylvania, Philadelphia, used both the AAV2 and AAV8 forms of the virus to deliver the foreign genes into monkeys and used a green fluorescent protein to test what dose of virus was required. They measured the success of delivery by detecting the fluorescent protein in the eyes of treated animals. AAV8 in this case worked slightly better than AAV2 serotype.

The eye is one of the few parts of the body where the insertion of foreign genes does not trigger inflammatory immune responses, making it a suitable target for gene therapies.

The research was published in the journal Science Translational Medicine.


SOURCES & REFERENCES
Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey
Science Translational Medicine |  22 June 2011
Gene therapy success in monkeys may help cure human blindness one day
India Daily |  24 June 2011
Monkeys get glow-in-the-dark eyes
New Scientist |  23 June 2011
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
31 October 2011 - by Victoria Kay 
A British man has become the first person to receive an advanced gene therapy treatment in a bid to save his sight. Jonathan Wyatt, aged 63, is the first of 12 patients to have the experimental procedure to try and halt the progression of his genetic eye disorder, choroideraemia. While he still has some sight, if left untreated, he would eventually become blind...
26 September 2011 - by Dr Rachael Panizzo 
UK scientists have been granted approval to begin the first clinical trial using embryonic stem cells (ES cells) in Europe, which they hope could lead to an effective treatment for a degenerative eye disease causing blindness...
30 August 2011 - by Rosemary Paxman 
Over a dozen children with 'boy in bubble' syndrome are alive and well, with functioning immune systems, nine years after undergoing gene therapy to correct their disorder, researchers report....
22 August 2011 - by Daniel Malynn 
Rise of the Planet of the Apes is this summer's big blockbuster and is directed by Rupert Wyatt. The film is a prequel to the other Planet of the Apes films and charts how the apes came to revolt. The basic storyline is thus; Dr Will Rodman (James Franco) is testing a gene therapy called ALZ-112 on chimps to find a cure for degenerative diseases like Alzheimer's...
1 November 2009 - by Dr Marianne Kennedy 
US doctors have used gene therapy to restore significant vision in 12 patients who were previously blinded by a disease called Leber's congenital amaurosis. The study, conducted by researchers at the Children`s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, was published online in the Lancet on 24 October....
21 September 2009 - by Sarah Pritchard 
Scientists in the USA have used gene therapy to restore full vision to two male squirrel monkeys with red-green colour blindness, raising hopes that the technique might one day be used to treat humans. The researchers injected both monkeys with the human form of a gene which enables detection of the colour red. Five months after the treatment, the monkeys were able to successfully identify a red pattern on a background of grey dots....
17 August 2009 - by Dr Rebecca Robey 
A phase I clinical trial in the US has successfully used gene therapy to improve vision in individuals suffering from a rare form of hereditary blindness. The promising results of this trial pave the way for future trials and may eventually lead to a cure for several forms of congenital blindness...
28 April 2008 - by Ailsa Stevens 
Four people with a rare inherited condition which leads to blindness in childhood have reportedly experienced improved vision after taking part in the world's first trials of an experimental gene therapy, according to two independent studies published online in the New England Journal of Medicine. Professor Robin...
30 May 2007 - by Katy Sinclair 
A team of University of Florida researchers has restored sight to mice with hereditary blindness by using a harmless virus to deliver therapuetic genes. In a paper published in Nature Medicine, the scientists describe how their research proved it was possible to target and rescue cone cells...
9 May 2007 - by Ailsa Stevens 
Researchers at University College London are the first in the world to attempt to use gene therapy to treat a rare inherited condition which leads to blindness in childhood. The disease, known as Leber Congenital Syndrome (LCS), is caused by an abnormality in the RPE65 gene, which...
14 August 2005 - by BioNews 
US scientists have used gene therapy to successfully treat mice with a rare genetic disorder that causes blindness, called retinoschisis. The researchers, based at the University of Florida Genetics Institute, say their method could eventually be used to treat a range of eye diseases in humans. Retinoschisis causes the retina...
20 September 2004 - by BioNews 
The first clinical trial based on a promising new technology called RNA interference (RNAi) is set to begin in the US, to treat a progressive eye disorder. The researchers hope to test the safety of the technique for treating a disease called wet age-related macular degeneration (AMD). This condition, which...
29 March 2004 - by BioNews 
Gene therapy trials for haemophilia, muscular dystrophy and childhood blindness are to receive £3 million funding, the UK Department of Health has announced. A further £1 million has been set aside for research into the long-term safety of some gene therapy techniques. The funding is part of a £50 million...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.